Location Ann Arbor, Michigan, United States Regions Great Lakes, Midwestern US Gender Male
Tom was previously an Executive-in-Residence of the Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan where he taught a class on managing the growth of new ventures at the Ross School and manages the School’s student-led Frankel Commercialization Fund, a seed and pre-seed venture capital fund
having teams investing in Technology, Healthcare, Cleantech, and Consumer products.
Previously, Tom co-founded and is a former general partner in EDF Ventures, an Ann Arbor-based venture capital firm investing in early-stage companies in healthcare and information technology. At EDF he lead the healthcare practice where he founded five companies based on technology from Michigan universities: Theragen Inc.(now GENVEC, GNVC on NASDAQ), Coagulation Systems Inc., Selective Genetics Inc., IntraLase Corp. (purchased by Abbott following a successful IPO), and HandyLab Inc. (purchased by Becton Dickinson), creating more than $1 billion in exit values for investors.
